SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Keravision(kera)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: trevor john wilkinson who wrote ()8/8/1999 10:59:00 PM
From: Phil  Read Replies (1) of 338
 
Lots of bad publicity for refractive surgery lately.

Found this and thought I'd share. Recommend you read the entire paper.

>>>http://www.slackinc.com/eye/jrs/vol115/9ed.htm

Evaluating New Refractive Surgical Procedures:
Free Market Madness Versus Regulatory Rigor Mortis
George O. Waring III, MD, FACS, FRCOphth

PROPOSALS FOR MORE RATIONAL EVALUATION
How can refractive surgeons and commercial firms most responsibly introduce and evaluate new refractive surgical procedures, encourage innovation and early adaptors, and at the same time prevent complications in large numbers of patients? Consider 10 idealistic proposals:

Many surgeons and companies are developing new refractive surgery techniques in the general spirit of these precepts, although they have not completely escaped the influences of premarket madness and regulatory rigor mortis:

Intracorneal ring for myopia,(22)
Holmium:YAG thermokeratoplasty (see the article by Ariyasu and colleagues on page 358 in this issue),
The prospective trial of the Casebeer/Chiron system of radial and transverse keratotomy,(23)
The FDA trials of excimer laser photorefractive keratectomy and LASIK in the United States,(24)
Nd:YAG and Nd:YSGG laser intrastromal photodisruption,(25)
Intracorneal lens for presbyopia,
Iris claw(26) and posterior plate myopia intracorneal lenses (see brief report by Erturk on page 388 in this issue).
Vigorous investigation and honest disclosure of results coupled with personal restraint and a patient-as-partner philosophy allow us to evaluate new refractive surgery procedures without succumbing to either free market madness or regulatory rigor mortis.<<<

Of course you can find this link later at:
home.att.net

Best to all,
Phil
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext